Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Dermatologic 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Neoplasms 15Breast Neoplasms 13Stomach Neoplasms 12Prostatic Neoplasms 12Colorectal Neoplasms 11Pancreatic Neoplasms 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Endometrial Neoplasms 5Colonic Neoplasms 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Skin Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2Rectal Neoplasms 2Peritoneal Neoplasms 2Papillomavirus Infections 2Obesity 2Multiple Myeloma 2

Interventions

Surveys and Questionnaires 5Blood Specimen Collection 3Spectrum Analysis, Raman 2Observation 2Mohs Surgery 2Microscopy, Confocal 2Intravital Microscopy 2Immunotherapy 2Dermoscopy 2Biopsy 2trametinib 1teriflunomide 1sonidegib 1pembrolizumab 1dabrafenib 1Workplace 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Specimen Handling 1Solid Phase Microextraction 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Natalizumab 1Molecular Diagnostic Techniques 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Skin Neoplasms × Observation × Clear all
NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Intergruppo Melanoma Italiano

Recruiting
270 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡